The mycobiome: Role in health and disease, and as a potential probiotic target in gastrointestinal disease

Digestive and Liver Disease

Volumn 49, Issue 11, 2017, Pages 1171-1176

  Hager, Christopher L ^a   Ghannoum, Mahmoud A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Fungus; Inflammatory bowel disease; Probiotics

Indexed keywords

ANTIFUNGAL AGENT; PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; ANTIFUNGAL THERAPY; BACTERIUM; COOPERATION; CROHN DISEASE; DRUG TARGETING; FUNGUS; HEALTH; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MICROBIAL COMMUNITY; MICROORGANISM; MYCOBIOME; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CANDIDA TROPICALIS; ESCHERICHIA COLI; MICROBIOLOGY; ORGANISMAL INTERACTION; PHYSIOLOGY; SERRATIA MARCESCENS;

ANIMALS; CANDIDA TROPICALIS; ESCHERICHIA COLI; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; MICROBIAL INTERACTIONS; MYCOBIOME; PROBIOTICS; SERRATIA MARCESCENS;

EID: 85030454499     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2017.08.025     Document Type: Review

References (39)

1. Hoarau, G., Mukherjee, P.K., Gower-Rousseau, C., Hager, C., Chandra, J., Retuerto, M.A., et al. Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn's disease. mBio, 2016.
2. Ghannoum, M.A., Jurevic, R.J., Mukherjee, P.K., Cui, F., Sikaroodi, M., Naqvi, A., et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog, 6, 2010, e1000713.
3. Dollive, S., Peterfreund, G.L., Sherrill-Mix, S., Bittinger, K., Sinha, R., Hoffmann, C., et al. A tool kit for quantifying eukaryotic rRNA gene sequences from human microbiome samples. Genome Biol, 13, 2012, R60.
4. Hoffmann, C., Dollive, S., Grunberg, S., Chen, J., Li, H., Wu, G.D., et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS ONE, 8, 2013, e66019.
5. Arnolds, Kathleen L., Lozupone, Catherine A., Striking a balance with help from our little friends — how the gut microbiota contributes to immune homeostasis. Yale J Biol Med 89 (2016), 389–395.
6. Baumgart, D.C., Sandborn, W.J., Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369 (2007), 1641–1657.
7. Odds, F.C., Candida and Candidosis. 1988, Bailliere Tindall, 156–163.
8. Parrot, J., Note sur un cas de muguet du gros intestine. Arch Physiol Norm Pathol 3 (1870), 621–625.
9. Parrot, J., Du muguet gastrique et de quelques autres localisations de ce parasite. Arch Physiol Norm Pathol 2 (1869), 579–599.
10. Iliev, I.D., Funari, V.A., Taylor, K.D., Nguyen, Q., Reyes, C.N., Strom, S.P., et al. Interactions between commensal fungi and the C-type lectin receptor dectin-1 influence colitis. Science 336 (2012), 1314–1317.
11. Schloss, P.D., Iverson, K.D., Petrosino, J.F., Schloss, S.J., The dynamics of a family's gut microbiota reveal variations on a theme. Microbiome, 2, 2014, 25.
12. Chandra, J., Mukherjee, P.K., Ghannoum, M.A., In vitro growth and analysis of Candida biofilms. Nat Protoc 3 (2008), 1909–1924.
13. Schloss, P.D., Iverson, K.D., Petrosino, J.F., Schloss, S.J., The dynamics of a family's gut microbiota reveal variations on a theme. Microbiome, 2, 2014, 25.
14. Chassaing, B., Darfeuille-Michaud, A., The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 141 (2011), 1720–1728.
15. Lamas, B., Richard, M.L., Leducq, V., Pham, H.P., Michel, M.L., Da Costa, G., et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med 22 (2016), 598–605.
16. Chandra, J., Zhou, G., Ghannoum, M.A., Fungal biofilms and antimycotics. Curr Drug Targets 6 (2005), 887–894.
17. Ochieng, J.B., Boisen, N., Lindsay, B., Santiago, A., Ouma, C., Ombok, M., et al. Serratia marcescens is injurious to intestinal epithelial cells. Gut Microbes 5 (2014), 729–736.
18. Standaert-Vitse, A., Sendid, B., Joossens, M., Francois, N., Vandewalle-El Khoury, P., Branche, J., et al. Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol 104 (2009), 1745–1753.
19. Chouraki, V., Savoye, G., Dauchet, L., Vernier- Massouille, G., Dupas, J.L., Merle, V., et al. The changing patern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007) 1133–1142. Aliment Pharmacol Ther 33 (2011), 1988–2007.
20. Sokol, H., Leducq, V., Aschard, H., Pham, H.P., Jegou, S., Landman, C., et al. Fungal microbiota dysbiosis in IBD. Gut, 2016.
21. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7 (2010), 335–336.
22. Cavalcanti, Y.W., Morse, D.J., da Silva, W.J., Del-Bel-Cury, A.A., Wei, X., Wilson, M., et al. Virulence and pathogenicity of Candida albicans is enhanced in biofilms containing oral bacteria. Biofouling 31 (2015), 27–38.
23. Standaert-Vitse, A., Jouault, T., Vandewalle, P., Mille, C., Seddik, M., Sendid, B., et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology 120 (2006), 1764–1775.
24. Muller, S., Schaffer, T., Flogerzi, B., Seibold-Schmid, B., Schnider, J., Takahashi, K., et al. Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens. Gut 59 (2010), 1493–1500.
25. Gower-Rousseau, C., Salomez, J.L., Dupas, J.L., Marti, R., Nuttens, M.C., Votte, A., et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 35 (1994), 1433–1438.
26. Chandra, J., Mukherjee, P.K., Ghannoum, M.A., In vitro growth and analysis of Candida biofilms. Nat Protoc 3 (2008), 1909–1924.
27. Mukhopadhya, I., Hansen, R., Meharg, C., Thomson, J.M., Russell, R.K., Berry, S.H., et al. The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes Infect 17 (2015), 304–310.
28. Chandra, J., Retuerto, M., Mukherjee, P.K., Ghannoum, M., The fungal biome of the oral cavity. Methods Mol Biol 1356 (2016), 107–135.
29. Castro, D.P., Seabra, S.H., Garcia, E.S., de Souza, W., Azambuja, P., Trypanosoma cruzi: ultrastructural studies of adhesion, lysis and biofilm formation by Serratia marcescens. Exp Parasitol 117 (2007), 201–207.
30. Sendid, B., Quinton, J.F., Charrier, G., Goulet, O., Cortot, A., Grandbastien, B., et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 93 (1998), 1306–1310.
31. Grishin, A., Papillon, S., Bell, B., Wang, J., Ford, H.R., The role of the intestinal microbiota in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg 22 (2013), 69–75.
32. Edgar, R.C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26 (2010), 2460–2461.
33. Kalan, L., Loesche, M., Hodkinson, B.P., Heilmann, K., Ruthel, G., Gardner, S.E., et al. Redefining the chronic-wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing. mBio, 7, 2016 e01058-16.
34. Mendes, A., Mores, A.U., Carvalho, A.P., Rosa, R.T., Samaranayake, L.P., Rosa, E.A., Candida albicans biofilms produce more secreted aspartyl protease than the planktonic cells. Biol Pharm Bull 30 (2007), 1813–1815.
35. Kong, E.F., Tsui, C., Kucharikova, S., Andes, D., Van Dijck, P., Jabra-Rizk, M.A., Commensal protection of Staphylococcus aureus against antimicrobials by Candida albicans biofilm matrix. mBio, 7, 2016 e01365-16.
36. De Brucker, K., Tan, Y., Vints, K., De Cremer, K., Braem, A., Verstraeten, N., et al. Fungal β-1,3-glucan increases ofloxacin tolerance of Escherichia coli in a polymicrobial E. coli/Candida albicans biofilm. Antimicrob Agents Chemother 59 (2015), 3052–3058.
37. Png, C.W., Linden, S.K., Gilshenan, K.S., Zoetendal, E.G., McSweeney, C.S., Sly, L.I., et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105 (2010), 2420–2428.
38. Colina, A.R., Aumont, F., Deslauriers, N., Belhumeur, P., de Repentigny, L., Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect Immun 64 (1996), 4514–4519.
39. Sartor, R.B., Efficacy of probiotics for the management of inflammatory bowel disease. Gastroenterol Hepatol 7 (2011), 606–608.